Investing
150182 Articles
CVS Health is not one of the biggest names that investors generally think of when it comes to multi-billion capital…
For active traders and investors looking for juiced up returns in the hot biotech sector, ProShares has launched two triple…
Wal-Mart says it has taken steps to remove all items promoting the Confederate flag. However, a review of Walmart.com shows…
Oppenheimer's Holden Lewis has reiterated his Outperform rating and $26 price target on ExOne, after remodeling the stock after the…
Credit Suisse has taken a Neutral stance on the restaurant segment, but it has picked some winners that it sees…
Energy XXI could have a solid bounce heading its way if Canaccord Genuity is correct in its latest research report.
Of the closed-end funds covered in a recent Merrill Lynch report, 24/7 Wall St. has focused on four top muni…
24/7 Wall St. has reviewed some recent analyst calls supporting AT&T's movement and some background on the merger with DirecTV.
Lipocine may have a huge hit on its hands with the first swallowable oral testosterone treatment.
The U.S. Census Bureau and the Department of Housing and Urban Development reported Tuesday morning that sales of new homes…
The Federal Housing Finance Agency (FHFA) reported this morning that U.S. home prices rose 0.3% month over month in April.
A new research report from Piper Jaffray zeroes in on the firm’s top Focus Calls for investors to buy now.
Carnival released its fiscal second-quarter financial results Tuesday before the markets opened.
The closed-end funds featured in this multi-part report include some tax-free yielding municipal funds, senior loan funds, high-yield funds and…
PhotoMedex has announced that it will be selling its XTRAC and VTRAC psoriasis and vitiligo treatment businesses to MELA Sciences.
Our top personal finance-related articles today. Your wallet will thank you later.